跳至主要内容
临床试验/EUCTR2011-005627-40-NL
EUCTR2011-005627-40-NL进行中(未招募)1 期

Comparison of effectiveness of hepatitis B revaccination schemes in healthy non-responders - RESPONSE (Revaccination Hepatitis B prospective trial in non responders)

未提供0 个研究点目标入组 480 人开始时间: 2012年7月19日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
480

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - age:>18 yrs, or <80 yrs
  • - primo vaccination schedule of 3 vaccinations
  • - anti-HBs titer after 1 month after last hepatitis B vaccination < 10 IU/l
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 480
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - age:< 18 yrs, or >80 yrs
  • - immunocompromised due to disease of immunosuppresive medication
  • - pregnancy
  • - primo vaccination schedule < 3 vaccinations or > 3 vaccinations
  • - primo vaccination schedule with >1 type of recombinant vaccine
  • - positive hepatitis B antigen (HBsAg) or anti-hepatitis B core antibodies (anti-HBc)
  • - anti-HBs titer> 10 IU/l

研究者

发起方
未提供

相似试验